Improved synthesis of fenofibrate as lipid-lowering drug

被引：0
|
作者：
Man, Lili [1 ]
Li, Shuliang [2 ]
Yang, Hanyue [2 ]
Yan, Xianguang [2 ]
Dong, Shubo [2 ]
Zhang, Zhenming [3 ]
机构：
[1] School of Pharmacy, Jiangsu Ocean University, Jiangsu, Lianyungang,222005, China
[2] Jiangsu Deyuan Pharmaceutical Co., Ltd., Jiangsu, Lianyungang,222047, China
[3] School of Environmental and Chemical Engineering, Jiangsu Ocean University, Jiangsu, Lianyungang,222005, China
来源：
Jingxi Huagong/Fine Chemicals | 2023年 / 40卷 / 07期
关键词：
D O I：
10.13550/j.jxhg.20220880
中图分类号：
学科分类号：
摘要：
22
引用
收藏
页码：1505 / 1512
相关论文
共 50 条
  • [41] Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future
    Stein, Evan A.
    Raal, Frederick J.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (11)
  • [42] Expert commentary: Gastrointestinally active lipid-lowering drug safety
    Toth, Peter P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (6A): : 56C - 58C
  • [43] Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future
    Evan A. Stein
    Frederick J. Raal
    Current Cardiology Reports, 2015, 17
  • [44] Fenofibrate exposure and inflammatory response in the NHLBI Genetics of Lipid-Lowering Drugs and Diet Network Study
    Peacock, JM
    Pankow, JS
    Straka, RJ
    Tsai, MY
    Ordovas, JM
    Province, MA
    Arnett, DK
    CIRCULATION, 2006, 113 (08) : E340 - E340
  • [45] 2009 Drug Utilization and Cost Trends in Lipid-Lowering Agents
    Theodorou, Anna A.
    Johnson, Kelly M.
    Szychowski, John A.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2010, 2 (04) : 279 - 285
  • [46] MONITORING OF PATIENTS UNDER LIPID-LOWERING DRUG-THERAPY
    FARNIER, M
    SEMAINE DES HOPITAUX, 1993, 69 (14): : 417 - 420
  • [47] Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
    Neuvonen, Pertti J.
    Niemi, Mikko
    Backman, Janne T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (06) : 565 - 581
  • [48] Vascular effects of estradiol combined with the lipid-lowering drug fluvastatin
    Mueck, AO
    Seeger, H
    Deuringer, FU
    Wallwiener, D
    9TH INTERNATIONAL MENOPAUSE SOCIETY WORLD CONGRESS ON THE MENOPAUSE, 1999, : 269 - 272
  • [49] New oral lipid-lowering drug bempedoic acid for hyperlipidemia
    Einecke D.
    MMW - Fortschritte der Medizin, 2020, 162 (9) : 73 - 73
  • [50] COMPARATIVE-EVALUATION OF THE LIPID-LOWERING EFFECTS OF FENOFIBRATE AND PANTETHINE IN TYPE-II HYPERLIPOPROTEINEMIA
    RUBBA, P
    POSTIGLIONE, A
    DESIMONE, B
    LAMENZA, F
    MONTEFUSCO, S
    MANCINI, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1985, 38 (05): : 719 - 727
12345